Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Melamed

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
European Journal of Ophthalmology|April 7, 2007
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionF Topouzis, S Melamed, H Danesh-Meyer, et al.
Psychological Medicine|March 26, 2013
Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinationsS Zelber-Sagi, S Toker, G Armon, et al.
Nature Cardiovascular Research|August 28, 2024
Reward system activation improves recovery from acute myocardial infarctionH Haykin, E Avishai, M Krot, et al.
Ophthalmology|January 1, 1989
A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatmentS I Rakofsky, S Melamed, J S Cohen, et al.
Current Pharmaceutical Biotechnology|March 5, 2010
Optical and electrical interfacing technologies for living cell bio-chipsY Shacham-Diamand, S Belkin, J Rishpon, et al.
Eneurologicalsci|August 11, 2018
Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with CopaxoneS Melamed-Gal, P Loupe, B Timan, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
European Journal of Ophthalmology|April 7, 2007
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionF Topouzis, S Melamed, H Danesh-Meyer, et al.
Psychological Medicine|March 26, 2013
Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinationsS Zelber-Sagi, S Toker, G Armon, et al.
Nature Cardiovascular Research|August 28, 2024
Reward system activation improves recovery from acute myocardial infarctionH Haykin, E Avishai, M Krot, et al.
Ophthalmology|January 1, 1989
A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatmentS I Rakofsky, S Melamed, J S Cohen, et al.
Current Pharmaceutical Biotechnology|March 5, 2010
Optical and electrical interfacing technologies for living cell bio-chipsY Shacham-Diamand, S Belkin, J Rishpon, et al.
Eneurologicalsci|August 11, 2018
Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with CopaxoneS Melamed-Gal, P Loupe, B Timan, et al.
Pageof 16